269 related articles for article (PubMed ID: 2504519)
1. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.
Bowlin TL; Rosenberger AL; McKown BJ
Clin Exp Immunol; 1989 Jul; 77(1):151-6. PubMed ID: 2504519
[TBL] [Abstract][Full Text] [Related]
2. Effects of cyclosporin A and alpha-difluoromethylornithine on the growth of hamster pancreatic cancer in vitro.
Saydjari R; Townsend CM; Barranco SC; James E; Thompson JC
J Natl Cancer Inst; 1986 Nov; 77(5):1087-92. PubMed ID: 3022056
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
4. Increased ornithine decarboxylase activity and polyamine biosynthesis are required for optimal cytolytic T lymphocyte induction.
Bowlin TL; McKown BJ; Sunkara PS
Cell Immunol; 1987 Mar; 105(1):110-7. PubMed ID: 3102080
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
[TBL] [Abstract][Full Text] [Related]
6. Difluoromethylornithine (DFMO) arrests murine CTL development in the late, pre-effector stage.
Schall RP; Sekar J; Tandon PM; Susskind BM
Immunopharmacology; 1991; 21(2):129-43. PubMed ID: 1831810
[TBL] [Abstract][Full Text] [Related]
7. Effect of polyamine depletion in vivo by DL-alpha-difluoromethylornithine on functionally distinct populations of tumoricidal effector cells in normal and tumor-bearing mice.
Bowlin TL; McKown BJ; Davis GF; Sunkara PS
Cancer Res; 1986 Nov; 46(11):5494-8. PubMed ID: 3093066
[TBL] [Abstract][Full Text] [Related]
8. Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice.
Bowlin TL; Hoeper BJ; Rosenberger AL; Davis GF; Sunkara PS
Cancer Res; 1990 Aug; 50(15):4510-4. PubMed ID: 2114941
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of alloantigen-induced cytolytic T lymphocytes in vitro with (2R,5R)-6-heptyne-2,5-diamine, an irreversible inhibitor of ornithine decarboxylase.
Bowlin TL; Davis GF; McKown BJ
Cell Immunol; 1988 Feb; 111(2):443-50. PubMed ID: 3123076
[TBL] [Abstract][Full Text] [Related]
10. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
Sunkara PS; Rosenberger AL
Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive effects of cyclosporin A on cloned T cells.
Herold KC; Lancki DW; Moldwin RL; Fitch FW
J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
[TBL] [Abstract][Full Text] [Related]
12. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
Susskind BM; Chandrasekaran J
J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
[TBL] [Abstract][Full Text] [Related]
14. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
[TBL] [Abstract][Full Text] [Related]
15. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.
Heeg K; Gillis S; Wagner H
J Immunol; 1988 Oct; 141(7):2330-4. PubMed ID: 3262657
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
[TBL] [Abstract][Full Text] [Related]
17. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.
Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V
J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
Pereira GM; Miller JF; Shevach EM
J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
Takigawa M; Verma AK; Simsiman RC; Boutwell RK
Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
